Emory University broke ground on a $260 million biomedical research facility in December of 2019 in Atlanta. Designed by HOK to promote synergy and innovation, the multidisciplinary building will offer 346,000 sf of dedicated research space for programs in biomedical engineering, imaging sciences, cardiovascular medicine, oncology, pediatric health, inflammation, emerging infections, and immunity and immunotherapeutics.
Vermeulens has released its market outlook report for the third quarter of 2019. Key points include:
HALIX opened a 72,000-sf biopharmaceutical development and manufacturing center in November of 2019 at Leiden Bio Science Park in the Netherlands. The five-story structure provides BSL-2 cleanrooms with unidirectional process flows that can easily be upgraded to BSL-3 as needed. A manufacturing line with a 250-liter bioreactor capacity supports the production of viral vaccines and viral vectors, while a separate protein manufacturing area accommodates single-use bioreactors with a capacity of up to 1,000 liters.
The Ohio State University is planning to construct two collocated research facilities in its West Campus innovation district in Columbus. Designed by Pelli Clarke & Partners and Moody Nolan, the 305,000-sf Interdisciplinary Research Facility will provide a vivarium, support spaces, and wet, computational, and core labs for programs in engineering and medical research.
Thermo Fisher Scientific opened a $90 million viral vector facility in December of 2019 in Lexington, Mass. Featuring specialized GMP laboratories, the 50,000-sf project will accommodate the development, testing, and manufacture of viral vectors for the creation of gene and cell therapies. The center will act as a CDMO (contract development and manufacturing organization) site and will offer services including from drug development through clinical trials and commercial production.
Florida Atlantic University hosted a ceremonial groundbreaking for its $35 million Neuroscience Building in Jupiter in November of 2019. Construction will begin in summer of 2020 on the facility, which will provide shared research labs, faculty offices, a business incubator, and instructional space for programs in neuroscience, biotechnology, bioengineering, bioinformatics, and chemistry. The 58,000-sf project is strategically sited on the John D.
AZI is constructing an 85,000-sf isoptope production and research facility in Bunker Hill, Ind. The $44.5 million project includes the expansion of a 55,000-sf shell building by 30,000 sf to accommodate a 280,000-pound 70MeV cyclotron. The existing structure was purchased at a cost of $2.8 million. AZI (Arizona Isotopes Science Research Corp.) is based in Phoenix and supplies medical isotopes to companies and institutions worldwide. The facility is strategically sited near the Grissom Aeroplex, a public and military airport with a 12,500-sf runway.
Michigan State University broke ground on the $85 million Doug Meijer Innovation Building in Grand Rapids in November of 2019. Designed by SmithGroup, the 205,000-sf facility will house multiple tenants including Spectrum Health, BAMF Health, and MSU's College of Human Medicine. The collaborative six-story building will enable the discovery and commercialization of new medical devices, artificial intelligence technologies, and treatments for cancer and dementia.
Stanford University opened a $256 million biomedical research complex in November of 2019 in Stanford, Calif. Designed by Ennead Architects, the four-story, 235,000-sf project includes the Stanford ChEM-H (Chemistry, Engineering & Medicine for Human Health) Building and the Stanford Neurosciences Building, which houses the Wu Tsai Neurosciences Institute.
The University of Texas Rio Grande Valley broke ground in November of 2019 on the $30 million Institute for Neuroscience in Harlingen. Designed by Muñoz & Co. Architects, the 32,570-sf translational research facility will provide integrated laboratory, diagnostic, and clinical spaces where doctors and scientists can collaboratively develop innovative therapies for neuropsychiatric disorders.
Cold Spring Harbor Laboratory opened the Center for Therapeutic Research in late October of 2019 in Cold Spring Harbor, N.Y. Designed by Centerbrook Architects and Planners, the $75 million project involved the renovation and expansion of the existing Demerec Laboratory to create a 26,000-sf biomedical facility for the creation of advanced therapies for genetic diseases including cancer, diabetes, obesity, and autism.
Great Ormond Street Hospital opened the £42 million Zayed Centre for Research into Rare Disease in Children in October of 2019 in London. Developed in partnership with University College London, the 140,000-sf translational research facility collocates biomedical laboratories, GMP manufacturing suites, clinical spaces, and offices to enable the creation of innovative medical devices and personalized gene and cell therapies.
Florida Institute of Technology will break ground in spring of 2020 on the $18 million Health Sciences Research Center in Melbourne, Fla. Enabling the university to expand its biomedical engineering and premedical programs, the 61,000-sf facility will include a sophisticated anatomy lab with virtual dissection tables, an imaging suite with florescent and laser scanning microscopes, and labs for orthopedic research, tissue engineering, and computer modeling and simulation. The three-story center will also provide 20,000 sf of instructional and training space.
Rowan University and Rutgers University opened the $70 million Joint Health Sciences Center in October of 2019 in Camden, N.J. Designed by HOK to accommodate multiple institutions, the $70 million project provides leading-edge labs and learning environments to empower joint research initiatives and promote interdisciplinary collaboration.
Seattle Children’s Research Institute opened the $300 million Building Cure in October of 2019. The 540,000-sf translational research facility provides advanced laboratories for the development of innovative treatments for pediatric cancer, sickle cell anemia, ADHD, and diabetes. One entire floor of the building houses the Cure Factory, a GMP cell-therapy manufacturing center for the creation of personalized medicine solutions.
